Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ).
SMS Pharmaceuticals Limited has incorporated a new wholly owned subsidiary, SMS coLab Private Limited, following approval from the Ministry of Corporate Affairs on 23 December 2025, with an authorised capital of Rs. 15 lakh and paid-up capital of Rs. 1 lakh. The new entity, positioned as a greenfield project within the pharmaceuticals industry, is intended to focus on manufacturing pharmaceutical products in new therapeutic categories, as well as undertaking research, development, production, commercialization and distribution of a wide range of pharmaceutical products and related equipment, signalling an expansion of SMS Pharmaceuticals’ operational footprint and future growth ambitions.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited operates in the pharmaceuticals industry, focusing on the research, development, manufacturing and marketing of active pharmaceutical ingredients, bulk drugs and medicinal products across various therapeutic categories for domestic and export markets.
Average Trading Volume: 40,346
Technical Sentiment Signal: Strong Buy
Current Market Cap: 29.19B INR
See more insights into SMSPHARMA stock on TipRanks’ Stock Analysis page.